In summary, we found a positive association of breast cancer risk with testosterone in post-menopausal women; an inverse association of risk with SHBG in post-menopausal women; and a positive association of risk with IGF-1 in both pre- and post-menopausal women. This evidence concerns the gene IGF1 and breast carcinoma.